Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma
Original Article
D.F. Bajorin, J.A. Witjes, J.E. Gschwend, M. Schenker, B.P. Valderrama, Y. Tomita, A. Bamias, T. Lebret, S.F. Shariat, S.H. Park, D. Ye, M. Agerbaek, D. Enting, R. McDermott, P. Gajate, A. Peer, M.I. Milowsky, A. Nosov, J.N.A. Jr., Jr., K. Tupikowski, L. Toms, B.S. Fischer, A. Qureshi, S. Collette, K. Unsal-Kacmaz, E. Broughton, D. Zardavas, H.B. Koon, and M.D. Galsky
N Engl J Med 2021;384:2102-2114
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course closed
This course closed on Saturday, June 3, 2023 - 11:59pm.